by rss feed | Oct 25, 2024 | Cryo-cell, Duke autism, News Feeds, Parent's Guide to Cord Blood Foundation
The Parent’s Guide to Cord Blood Foundation recently announced that Cryo-Cell and its long-time partner, a Duke pediatric cell therapy team, have made a key change. They will begin offering infusions of unrelated, unproven cord blood to pediatric patients with...
by rss feed | Oct 17, 2024 | Cryo-cell, Duke, Duke autism, News Feeds
Cord blood banker Cryo-Cell and Duke have had a long-running agreement. The potentially multi-million dollar deal has focused on the development of possible umbilical cord blood therapies for pediatric patients. A major first goal has been to open an infusion clinic,...
by rss feed | Jul 21, 2024 | Cryo-cell, News Feeds, ViaCord, weekly reads
The private cord blood bank industry has promised families all kinds of great things over the years. A typical ad for such cord blood banks might say, “Your child may need cord blood in the future for a cure.” The industry also often uses the analogy of...
by rss feed | Apr 17, 2023 | Autism, Cryo-cell, Duke Autism Center, News Feeds
Almost two years ago I publicly called on the FDA to freeze the unproven cord cell expanded access program (EAP) at the Duke Autism Center. Duke has been infusing kids with autism spectrum disorder (ASD) with unproven cord cells and requiring large payments for this....
by rss feed | Sep 6, 2022 | cord blood, Cryo-cell, News Feeds, Reviews, ViaCord, Viacord review
Viacord is one of the most well known firms in the for-profit cord blood banking industry. Today’s post is a review of the firm. I see concrete reasons for concern. What is Viacord? | Dubious autism claims | Viacord cost | Overall Review |...
by rss feed | Aug 26, 2022 | cord blood, Cryo-cell, Duke Autism Center, News Feeds, Reviews
In today’s post I review the cord blood firm Cryo Cell International and discuss specific concerns I have about it. A major issue is their plan to open a clinic selling unproven cord cell infusions to kids. I believe this is risky both for the firm and more...